SHIKARI® Q-PAL
Enzyme immunoassay for the quantitative determination of Palivizumab (Synagis®) in human serum and plasma
Enzyme immunoassay for the quantitative determination of Palivizumab (Synagis®) in serum and plasma. The Matriks Biotek Shikari Palivizumab ELISA has been especially developed for the quantitative analysis of Palivizumab in serum and plasma samples.
Click the diagram to see bigger
| Required Volume (µl) | 10 |
|---|---|
| Total Time (min) | 70 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 3 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (year) | 1 |
